Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow

Purdue Pharma is set to be sentenced to a $225 million criminal penalty, clearing the way for a $7 billion settlement from the Sackler family to address the opioid crisis. The settlement, approved in 2020, resolves federal and state lawsuits over Purdue's role in aggressively marketing OxyContin, contributing to the opioid epidemic.